Abstract
Background
While the shift to digital technologies is pervasive across multiple industries, the informed consent process for clinical trials remains largely paper-based. Given the inefficiencies in the traditional process and the increasing complexity of clinical studies, the current approach at times may raise challenges with respect to quality, compliance, participant understanding, and trial retention. Electronic informed consent (eConsent) is an enabling clinical technology to potentially address these issues by using multimedia components to create an interactive participant experience and improve data quality.
Methods
The TransCelerate eConsent Initiative conducted a multifaceted engagement approach to better understand the perceptions, experiences, and concerns of impacted stakeholders, including participants, sites, ethics committees, and health authorities.
Results
While all stakeholders were supportive of the use of multimedia components to deliver study information, several stakeholder-specific concerns were noted. Participant feedback, as collected through surveys (n = 3045) and an advisory board (n = 10), suggests that some participants may have data privacy concerns and a diversity of preferences for multimedia presentation. Site interviews (n = 9) suggest concerns related to additional operational activities and potential for technology failure. Health authorities’ feedback, through nonbinding meetings, was geographically varied; ethics committee feedback, through interviews, suggests concern over impact on operational process changes.
Conclusions
While the appetite for eConsent is increasing, involved stakeholders and industry must continue to raise awareness, communicate, and collaborate to develop appropriate technological capabilities, regulatory pathways, and operational processes to clear the path for mainstream use of eConsent.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hallian ZP, Forrest A, Uhlenbrauck G, Young S, McKinney R Jr. Barriers to change in the informed consent process: a systematic literature review. IRB Ethics Hum Res. 2016;38(3):1–10.
Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 2003;348(8):721–726.
Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001;358(9295):1772–1777.
Falagas ME, Korbila IP, Giannopoulou KP, Kondilis BK, Peppas G. Informed consent: how much and what do patients understand? Am J Surg. 2009;198(3):420–435.
Ellis PM, Butow PN, Tattersall MHN, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001; 19(15):3554–3561.
Lentz J, Kennett M, Perlmutter J, Forrest A. Paving the way to a more effective informed consent process: recommendations from the clinical trials transformation initiative. Contemp Clin Trials. 2016;49:65–69.
Rowbotham MC, Astin J, Greene K, Cummings SR. Interactive informed consent: randomized comparison with paper consents. PLoS One. 2013;8(3).
Karunaratne AS, Korenman SG, Thomas SL, Myles PS, Kome-saroff PA. Improving communication when seeking informed consent: a randomised controlled study of a computer-based method for providing information to prospective clinical trial participants. Med J Aust. 2010;192(7):388–392.
Vanaken H. eConsent study provides insights to shape industry adoption. Appl Clin Trials. 2016;25(8).
Kitzinger J. Qualitative research: introducing focus groups. BMJ. 1995;311(7000):299.
Clinical Trials Transformation Initiative: Informed Consent. https://www.ctti-clinicaltrials.org/files/ctti-informedconsent-recs.pdf
FDA. Use of electronic informed consent in clinical investigations questions and answers guidance for industry. FDA. 2015;(March).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vanaken, H., Masand, S.N. Awareness and Collaboration Across Stakeholder Groups Important for eConsent Achieving Value-Driven Adoption. Ther Innov Regul Sci 53, 724–735 (2019). https://doi.org/10.1177/2168479019861924
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479019861924